Transenterix Inc (NASDAQ:TRXC) shares gapped up prior to trading on Friday . The stock had previously closed at $1.54, but opened at $1.55. Transenterix shares last traded at $1.51, with a volume of 630,971 shares traded.

Separately, Zacks Investment Research upgraded shares of Transenterix from a “hold” rating to a “buy” rating and set a $0.75 target price for the company in a research report on Thursday, July 13th.

The company’s 50 day moving average is $1.14 and its 200 day moving average is $0.86. The firm’s market capitalization is $218.35 million.

A number of hedge funds and other institutional investors have recently made changes to their positions in TRXC. Global X Management Co. LLC raised its stake in Transenterix by 238.3% during the second quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock worth $235,000 after buying an additional 233,213 shares during the last quarter. LMR Partners LLP bought a new stake in Transenterix in the second quarter valued at $189,000. UBS Oconnor LLC bought a new stake in Transenterix in the second quarter valued at $390,000. Goldman Sachs Group Inc. increased its stake in Transenterix by 7,137.7% in the second quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock valued at $854,000 after purchasing an additional 1,186,575 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in Transenterix by 17.1% in the second quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock valued at $298,000 after purchasing an additional 61,034 shares in the last quarter.

COPYRIGHT VIOLATION NOTICE: “Transenterix Inc (TRXC) Shares Gap Up to $1.55” was published by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/transenterix-inc-trxc-shares-gap-up-to-1-55/1613595.html.

About Transenterix

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.